跳至主要内容
临床试验/NCT02855632
NCT02855632Unknown不适用

The Efficacy of G-CSF Against Adhesion Reformation After Hysteroscopic Adhesiolysis

Sir Run Run Shaw Hospital1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2016年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
240
试验地点
1
主要终点
Adhesion reformation rate

研究概览

简要总结

The purpose of this study is to investigate the efficacy of Granulocyte Colony Stimulating Factor(G-CSF) on decreasing adhesion reformation and improving fertility outcomes after hysteroscopic adhesiolysis in patients with moderate to severe intrauterine adhesions.

详细描述

After hysteroscopic adhesiolysis, patients with moderate to severe intrauterine adhesions will be allocated into 2 groups randomly, with COOK ballon and estrogen and progesterone sequential therapy given to prevent adhesion routinely. 7 day later, G-CSF or normal saline will be injected into the uterine cavity by Tom catheter after removing the balloon respectively. A second hysteroscopic examination will be performed in 2 months to check up the adhesion reformation. In addition, the endometrial thickness after surgery and fertility outcome will be followed up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Moderate and severe intrauterine adhesion patients(AFS score ≥5)
  • age 18-40
  • first time receiving hysteroscopic adhesiolysis
  • provided COOK balloon as adjuvant adhesion prevention treatment
  • accepting randomized trial

排除标准

  • Mild adhesion patients
  • uterine shape can't be restored in the end of surgery
  • abnormal chromosome phenotype
  • systemic disease
  • no fertility desire
  • contradiction of G-CSF injection.

研究组 & 干预措施

G-CSF

Experimental

G-CSF(1.8ml) will be injected into the uterine cavity by insemination catheter 7 days after first hysteroscopic adhesiolysis.

干预措施: G-CSF (Drug)

G-CSF

Experimental

G-CSF(1.8ml) will be injected into the uterine cavity by insemination catheter 7 days after first hysteroscopic adhesiolysis.

干预措施: hormone therapy (Drug)

G-CSF

Experimental

G-CSF(1.8ml) will be injected into the uterine cavity by insemination catheter 7 days after first hysteroscopic adhesiolysis.

干预措施: Cook balloon (Other)

Normal saline

Placebo Comparator

equal volume of normal saline(1.8ml) will be injected into the uterine cavity by insemination catheter 7 days after first hysteroscopic adhesiolysis.

干预措施: Normal saline (Drug)

Normal saline

Placebo Comparator

equal volume of normal saline(1.8ml) will be injected into the uterine cavity by insemination catheter 7 days after first hysteroscopic adhesiolysis.

干预措施: hormone therapy (Drug)

Normal saline

Placebo Comparator

equal volume of normal saline(1.8ml) will be injected into the uterine cavity by insemination catheter 7 days after first hysteroscopic adhesiolysis.

干预措施: Cook balloon (Other)

结局指标

主要结局

Adhesion reformation rate

时间窗: 2 months after first surgery

Adhesion reformation rate after first adhesiolysis

次要结局

  • Live birth rate(4 years after first surgery)
  • Pregnancy rate(3 years after first surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaona Lin

MD

Sir Run Run Shaw Hospital

研究点 (1)

Loading locations...

相似试验